עמוד 1 מ 21 תוצאות
BACKGROUND OF THE INVENTION
(1) Field of the Invention
This invention relates to certain mutant strains of Streptococcus mutans strain BHT-2(str), their mutagenesis and isolation from the parent strain, and their use as an effector strain in the replacement therapy of dental caries.
(2) Description
FIELD OF THE INVENTION
The present invention relates to co-processed carbohydrate systems that produce formulations that are directly compressible into solid dosage forms, some of which rapidly and completely dissolve and/or disintegrate in the oral cavity, preferably within about 60 seconds. The
FIELD OF THE INVENTION
The present invention relates to co-processed carbohydrate systems that produce formulations that are directly compressible into solid dosage forms, some of which rapidly and completely dissolve and/or disintegrate in the oral cavity, preferably within about 60 seconds. The
FIELD OF THE INVENTION
The present invention relates to co-processed carbohydrate systems that produce formulations that are directly compressible into solid dosage forms, some of which rapidly and completely dissolve and/or disintegrate in the oral cavity, preferably within about 60 seconds. The
TECHNICAL FIELD
The present invention relates to oral care compositions, including therapeutic rinses, tooth pastes and gels comprising a combination of a non-cariogenic carbohydrate and a polyalcohol. This invention further relates to a method for treating or preventing conditions in the mouth that
FIELD OF INVENTION
The present invention relates to a carbohydrate based gel pad infused with an infusing compound that provides sustained oral transmucosal delivery of the infusing compound across the buccal areas of the mouth.
SUMMARY OF INVENTION
The present invention provides an infused
BACKGROUND OF THE INVENTION
(1) Field of the Invention
This invention relates to certain mutant strains of Streptococcus mutans strain BHT-2(str), their mutagenesis and isolation from the parent strain, and their use as an effector strain in the replacement therapy of dental caries.
(2) Description
FIELD OF THE INVENTION
This invention relates to the use of magnetic resonance imaging (MRI) contrast agents to provide a superior image of internal body cavities. In particular this invention relates to a method for obtaining a superior image of the cervical cavity and fallopian tubes to determine
FIELD OF THE INVENTION
The field of art to which this invention pertains is medical devices useful in the treatment of obesity, more particularly removable medical devices that are implanted in the digestive tract of a human.
BACKGROUND OF THE INVENTION
According to studies reported by the Centers
FIELD OF THE INVENTION
This invention relates to mouth-soluble pharmaceutical compositions containing acetylcysteine for treating affections of the oral cavity.
KNOWN ART
It is known to use acetylcysteine as a mucolytic and expectorant for the purpose of fluidizing the dense viscous secretions of
BACKGROUND OF THE INVENTION
Carbohydrates are eaten either as simple sugars or as more complex molecules called polysaccharides, which are built up from simple sugar units and of which the starch of potatoes, bread, etc., is a well-known example. The body absorbs carbohydrates from the small
BACKGROUND OF THE INVENTION
Carbohydrates are eaten either as simple sugars or as more complex molecules called polysaccharides, which are built up from simple sugar units and of which the starch of potatoes, bread, etc., is a well-known example. The body absorbs carbohydrates from the small
BACKGROUND OF THE INVENTION
It is known that in animals and man, after the intake of starchy foodstuffs and beverages, hyperglycaemias arise which are caused by a rapid splitting of the starch by amylases of the digestive tract according to the following equation:
These hyperglycaemias are
The present invention relates to a chewable or disintegrative tablet comprising enteric coated aspirin particles, preferably compressed into tablet form using dextrose monohydrate, and sucralose.
BACKGROUND OF THE INVENTION
Pharmaceuticals intended for oral administration are typically provided in
RELATED APPLICATION
This application claims priority to U.S. application Ser. No. 10/961,563, filed on Oct. 8, 2004, the entire contents of which are incorporated herein by reference.
The present invention relates to a chewable or disintegrative tablet comprising enteric coated aspirin particles,